Syntrophin-dystrobrevin complex (SNT-DTB) (SNT-DTB)

The Syntrophin-dystrobrevin complex is a critical protein assembly within the larger dystrophin-associated glycoprotein complex (DGC), primarily located at the sarcolemma of skeletal and cardiac muscle (Source: UniProt, P60044). Syntrophins (alpha, beta, and gamma isoforms) are modular adapter proteins that use PDZ domains to recruit signaling molecules, such as neuronal nitric oxide synthase (nNOS) and various ion channels, to the cell membrane (Source: PubMed, 10648235). Dystrobrevins (alpha and beta) are dystrophin-related proteins that bind directly to syntrophins and the C-terminal region of dystrophin, providing structural stability and mediating intracellular signaling (Source: NCBI Gene, 1837). This complex is essential for maintaining the mechanical integrity of the muscle cell membrane during contraction and for coordinating signal transduction between the extracellular matrix and the cytoskeleton. Dysregulation or absence of this complex, typically due to dystrophin deficiency in Duchenne muscular dystrophy, leads to muscle wasting, membrane fragility, and impaired signaling (Source: StatPearls, NBK482288). Mutations in specific components, such as SNTA1, are also associated with cardiac conditions like Long QT syndrome (Source: PubMed, 17080015). While not traditionally targeted by small molecules, the complex is a primary focus for gene therapies and exon-skipping drugs, such as Eteplirsen, which aim to restore the DGC's functional assembly (Source: FDA, Eteplirsen Label).

Other names

Syntrophin-dystrobrevin subcomplexDystrophin-associated protein complex componentSNT-DTNA complexSyntrophin-dystrobrevin signaling module

Restoration of the dystrophin-associated glycoprotein complex (DGC) to stabilize the sarcolemma and recruit signaling molecules.